BD Buys CareFusion For $12.2 Billion
It’s the third largest medtech merger this year, and Becton Dickinson says its purchase of CareFusion will make it a medication management leader and strengthen its role as a hospital solutions provider focused on patient safety.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.